We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

180 hedge funds and large institutions have $930M invested in OptimizeRx in 2021 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $62.9M | Put options by funds: $39M

45% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 40

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

10% more funds holding

Funds holding: 163 → 180 (+17)

5.62% more ownership

Funds ownership: 78.77% → 84.39% (+5.6%)

22% less capital invested

Capital invested by funds: $1.19B → $930M (-$256M)

58% less funds holding in top 10

Funds holding in top 10: 12 → 5 (-7)

Holders
180
Holders Change
+17
Holders Change %
+10.43%
% of All Funds
2.77%
Holding in Top 10
5
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-58.33%
% of All Funds
0.08%
New
58
Increased
61
Reduced
49
Closed
40
Calls
$62.9M
Puts
$39M
Net Calls
+$23.9M
Net Calls Change
+$4.65M

Top Buyers

1
BlackRock
BlackRock
New York
+$118M
2
State Street
State Street
Massachusetts
+$21.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$20M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.9M
5
Morgan Stanley
Morgan Stanley
New York
+$12.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$43.9M
2
BCH
Berkshire Capital Holdings
California
-$28.7M
3
NCGI
Next Century Growth Investors
Minnesota
-$23M
4
PCA
Prospect Capital Advisors
California
-$14.9M
5
FLAM
First Light Asset Management
Minnesota
-$14.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$8.04M +$4.25M +56,140 +77%
BAM
27
Bullseye Asset Management
Colorado
$7.61M -$4.8M -63,292 -34%
VCM
28
Venator Capital Management
Ontario, Canada
$7.43M -$6.24M -82,300 -41%
CM
29
Castleark Management
Illinois
$7.07M -$3.4M -44,900 -28%
Invesco
30
Invesco
Georgia
$6.92M +$1.56M +20,631 +23%
PCM
31
Perkins Capital Management
Minnesota
$6.7M -$557K -7,350 -6%
HI
32
Handelsinvest Investeringsforvaltning
Denmark
$6.21M -$758K -10,000 -9%
WA
33
Wasatch Advisors
Utah
$5.79M +$944K +12,460 +15%
Calamos Advisors
34
Calamos Advisors
Illinois
$5.68M -$1.92M -25,299 -22%
LCG
35
Lisanti Capital Growth
New York
$5.43M -$1.07M -14,185 -14%
Marshall Wace
36
Marshall Wace
United Kingdom
$4.98M +$6.07M +80,164 New
Ameriprise
37
Ameriprise
Minnesota
$4.72M +$5.62M +74,108 +3,836%
Bank of America
38
Bank of America
North Carolina
$4.49M -$1.63M -21,516 -23%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$3.74M -$1.72M -22,672 -27%
Swedbank
40
Swedbank
Sweden
$3.67M -$379K -5,000 -8%
Mirae Asset Global Investments
41
Mirae Asset Global Investments
South Korea
$3.59M -$1.55M -20,411 -26%
Citigroup
42
Citigroup
New York
$3.49M +$3.92M +51,756 +1,149%
Allspring Global Investments
43
Allspring Global Investments
North Carolina
$3.29M +$4.01M +52,983 New
N
44
Nuveen
North Carolina
$3.14M -$376K -4,968 -8%
PCA
45
Prospect Capital Advisors
California
$2.86M -$14.9M -196,450 -81%
Legal & General Group
46
Legal & General Group
United Kingdom
$2.74M +$2.74M +36,162 +453%
Charles Schwab
47
Charles Schwab
California
$2.74M +$54K +713 +2%
PI
48
PEAK6 Investments
Illinois
$2.59M +$3.16M +41,676 New
EIM
49
Essex Investment Management
Massachusetts
$2.53M +$212K +2,800 +7%
RHJA
50
Rice Hall James & Associates
California
$2.42M -$536K -7,070 -15%
1
2
3 4 5

OPRX Hedge Fund Activity: Q4 2021 in Review

180 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2021, worth a combined $930M — down 22% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new OPRX positions and 40 closed out — a net gain of 18 holders — while 61 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $118M. The largest seller was Millennium Management, cutting an estimated $43.9M.

  • 180 institutional investors held OptimizeRx (OPRX) as of Q4 2021, up from 163 in Q3 2021.
  • Funds reported $930M of OptimizeRx stock for Q4 2021, down 22% quarter-over-quarter.
  • 58 funds opened new OptimizeRx positions in Q4 2021 and 40 closed out, a net change of +18 holders.
  • The largest OptimizeRx buyer in Q4 2021 was BlackRock, an estimated $118M added.
  • The largest OptimizeRx seller in Q4 2021 was Millennium Management, an estimated $43.9M sold.

Based on aggregated 13F filings for Q4 2021.